Medios AG

Historical price data

Medios AG is a publicly traded German company and a market leader in the European specialty pharmaceutical services sector. Its core mission is to enable the future of individualized medicine by ensuring the reliable, compliant supply of complex therapies to healthcare providers and patients. The company's strategy revolves around its integrated Pharmaceutical Care platform, combining specialty pharma distribution, patient-specific compounding, and therapy management services. Since its IPO in 2018, Medios has established a strong market position, reflected in its inclusion in the SDAX index, by navigating the intricate regulatory and logistical challenges of high-value medications.

An integrated Pharmaceutical Care platform combining specialty pharma sourcing & distribution, patient-specific GMP compounding, therapy management services, and tailored digital infrastructure for the complex logistics of high-value medications.

Medios competes with large, broad-line pharmaceutical wholesalers and smaller niche compounding pharmacies. Its primary advantage is its integrated, specialized service model for complex therapies, which is difficult for larger, less agile competitors or smaller, less comprehensive specialists to replicate effectively.